Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001457716-16-000115
Filing Date
2016-02-05
Accepted
2016-02-05 13:57:43
Documents
1

Document Format Files

Seq Description Document Type Size
1 SC 13G/A LGNDZ kcg2015033113ga.htm SC 13G/A 161738
  Complete submission text file 0001457716-16-000115.txt   163560
Mailing Address 11119 NORTH TORREY PINES ROAD SUITE 200 LA JOLLA CA 92037
Business Address 11119 NORTH TORREY PINES ROAD SUITE 200 LA JOLLA CA 92037 858-550-7500
LIGAND PHARMACEUTICALS INC (Subject) CIK: 0000886163 (see all company filings)

EIN.: 770160744 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-43329 | Film No.: 161391533
SIC: 2834 Pharmaceutical Preparations

Mailing Address 545 WASHINGTON BLVD. JERSEY CITY NJ 07310
Business Address 545 WASHINGTON BLVD. JERSEY CITY NJ 07310 201-356-1390
KCG AMERICAS LLC (Filed by) CIK: 0001457716 (see all company filings)

EIN.: 264219373 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A